"Tivic Health Systems is shifting its focus towards biopharmaceuticals, which could serve as a potential catalyst for future growth, though the company's recent sentiment remains subdued with an average score of 0.28. Risks include market volatility and uncertainty surrounding the effectiveness of its new strategic direction, leading some traders to consider averaging down on their positions."